Literature DB >> 32082879

The mid-term effect of left ventricular assist devices on renal functions.

Mustafa Emre Gürcü1, Özge Altaş Yerlikhan2, Tanıl Özer2, Atakan Erkılınç1, Ece Altınay1, Esin Erdem1, Murat Gücün3, Nural Bekiroğlu4, Kaan Kırali2.   

Abstract

BACKGROUND: In this study, we aimed to investigate the mid-term effects of left ventricular assist devices on kidney functions.
METHODS: Between January 2015 and December 2017, a total of 61 patients (53 males, 8 females; mean age 46.4±11.2 years; range, 20 to 67 years) who underwent left ventricular assist device implantation were retrospectively analyzed. Glomerular filtration rate was evaluated preoperatively and at 24 and 48 h, at one week, and at one, three, and six months postoperatively. According to the preoperative glomerular filtration rates, the patients were divided into three groups: glomerular filtration rates ?60 mL/min/1.73 m2 ( Group 1 ), g lomerular f iltration rates 61-90 mL/min/1.73 m2 (Group 2), and glomerular filtration rates >90 mL/min/1.73 m2 (Group 3).
RESULTS: In all groups, the glomerular filtration rate significantly increased at one week and one month postoperatively, compared to preoperative values (p<0.001 and p<0.01, respectively). However, the glomerular filtration values at six months significantly decreased, compared to the values at one week and one month postoperatively (p<0.001 and p<0.001, respectively). The most significant drop to preoperative values was observed in Group 3 (p=0.02) at three months and it dropped below the preoperative level at six months (p<0.001).
CONCLUSION: Our study results suggest that left ventricular assist devices can significantly increase the glomerular filtration rate in short-term, irrespective of baseline values. However, this improvement may recede later, particularly in patients with normal renal functions, and it may even disappear following the third postoperative month.
Copyright © 2019, Turkish Society of Cardiovascular Surgery.

Entities:  

Keywords:  End-stage heart failure; glomerular filtration rate; mechanical assist device; renal failure

Year:  2019        PMID: 32082879      PMCID: PMC7021439          DOI: 10.5606/tgkdc.dergisi.2019.17568

Source DB:  PubMed          Journal:  Turk Gogus Kalp Damar Cerrahisi Derg        ISSN: 1301-5680            Impact factor:   0.332


  24 in total

1.  Long-term use of a left ventricular assist device for end-stage heart failure.

Authors:  E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

2.  Effect of pulsatile left ventricular assist system implantation on Doppler measurements of renal hemodynamics in patients with advanced heart failure.

Authors:  Yoshio Iwashima; Masanobu Yanase; Takeshi Horio; Osamu Seguchi; Yoshihiro Murata; Tomoyuki Fujita; Kouichi Toda; Yuhei Kawano; Takeshi Nakatani
Journal:  Artif Organs       Date:  2011-10-14       Impact factor: 3.094

Review 3.  Implantable left ventricular assist devices and the kidney.

Authors:  Huijuan Mao; Nevin Katz; Jeong Chul Kim; Sonya Day; Claudio Ronco
Journal:  Blood Purif       Date:  2014-02-12       Impact factor: 2.614

4.  Changes in Aortic Wall Structure, Composition, and Stiffness With Continuous-Flow Left Ventricular Assist Devices: A Pilot Study.

Authors:  Amrut V Ambardekar; Kendall S Hunter; Ashok N Babu; Rubin M Tuder; R Blair Dodson; JoAnn Lindenfeld
Journal:  Circ Heart Fail       Date:  2015-07-01       Impact factor: 8.790

5.  Changes in renal function after implantation of continuous-flow left ventricular assist devices.

Authors:  Tal Hasin; Yan Topilsky; John A Schirger; Zhuo Li; Yanjun Zhao; Barry A Boilson; Alfredo L Clavell; Richard J Rodeheffer; Robert P Frantz; Brooks S Edwards; Naveen L Pereira; Lyle Joyce; Richard Daly; Soon J Park; Sudhir S Kushwaha
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

6.  Changes in End-Organ Function in Patients With Prolonged Continuous-Flow Left Ventricular Assist Device Support.

Authors:  Daisuke Yoshioka; Hiroo Takayama; Paolo C Colombo; Melana Yuzefpolskaya; Arthur R Garan; Veli K Topkara; Jiho Han; Paul Kurlansky; Yoshifumi Naka; Koji Takeda
Journal:  Ann Thorac Surg       Date:  2017-02-04       Impact factor: 4.330

7.  Smooth muscle cell hypertrophy of renal cortex arteries with chronic continuous flow left ventricular assist.

Authors:  Shin'ichiro Kihara; Kenneth N Litwak; Larry Nichols; Philip Litwak; Marina V Kameneva; Zhongjun Wu; Robert L Kormos; Bartley P Griffith
Journal:  Ann Thorac Surg       Date:  2003-01       Impact factor: 4.330

Review 8.  Renal failure in patients with left ventricular assist devices.

Authors:  Ami M Patel; Gbemisola A Adeseun; Irfan Ahmed; Nanhi Mitter; J Eduardo Rame; Michael R Rudnick
Journal:  Clin J Am Soc Nephrol       Date:  2012-10-11       Impact factor: 8.237

9.  Renal Function Changes Following Left Ventricular Assist Device Implantation.

Authors:  Usama A Daimee; Meng Wang; Anna Papernov; Saadia Sherazi; Scott McNitt; Himabindu Vidula; Leway Chen; Jeffrey D Alexis; Valentina Kutyifa
Journal:  Am J Cardiol       Date:  2017-09-19       Impact factor: 2.778

Review 10.  Left ventricular assist devices: a kidney's perspective.

Authors:  T R Tromp; N de Jonge; J A Joles
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.